Survodutide

Survodutide is a GLP-1/GCG receptor agonist under investigation for enhanced metabolic effects compared to single-pathway agonists. Research suggests it may produce robust weight loss and improved insulin sensitivity through dual pathway activation. This dual-action peptide represents emerging research into combined incretin agonism.